Related Experiment Videos
Neurofilament protein levels in CSF are increased in dementia
L E Rosengren1, J E Karlsson, M Sjögren
1Institute of Clinical Neuroscience, Department of Neurology, Sahlgrens University Hospital, University of Göteborg, Sweden.
Neurology
|April 2, 1999
Summary
CSF levels of neurofilament light protein (NFL) were elevated in patients with dementia, indicating white matter degeneration in vascular dementia, Alzheimer's disease, and frontotemporal dementia.
Area of Science:
- Neuroscience
- Biochemistry
- Neurology
Background:
- Neurofilaments are key components of the axonal cytoskeleton.
- Myelinated axons are crucial for rapid nerve signal transmission.
- Neurofilament light protein (NFL) is a potential biomarker for neurodegeneration.
Purpose of the Study:
- To investigate cerebrospinal fluid (CSF) levels of NFL in patients with dementia.
- To explore the relationship between CSF NFL levels and white matter integrity in dementia.
Main Methods:
- Cerebrospinal fluid (CSF) was collected from patients diagnosed with vascular dementia (VAD), Alzheimer's disease (AD), and frontotemporal dementia (FTD).
- CSF levels of the neurofilament light subunit (NFL) were measured.
- CSF NFL levels were compared between patient groups and neurologically healthy controls.
Main Results:
- CSF NFL levels were significantly increased in patients with VAD, AD, and FTD compared to healthy individuals.
- Elevated NFL suggests damage to myelinated axons, which are abundant in white matter.
Conclusions:
- Increased CSF NFL levels are indicative of white matter degeneration in VAD, AD, and FTD.
- NFL may serve as a valuable biomarker for assessing white matter damage in various dementia subtypes.